Skip to main navigation Skip to search Skip to main content

CheckMate 025: a randomized, open-label, phase Ill study of nivolumab versus everolimus in advanced renal cell carcinoma (RCC)

  • Robert J. Motzer
  • , Bernard Escudier
  • , David F. Mcdermott
  • , Saby George
  • , Hans J. Hammers
  • , Sandhya Srinivas
  • , Scott S. Tykodi
  • , Jeffrey A. Sosman
  • , Giuseppe Procopio
  • , Elizabeth R. Plimack
  • , Daniel Castellano
  • , Howard Gurney
  • , Frede Donskov
  • , Petri Bono
  • , John Wagstaff
  • , Thomas C. Gauler
  • , Takeshi Ueda
  • , Li-An Xu
  • , Ian M. Waxman
  • , Padmanee Sharma
  • CheckMate 025 Investigators

Research output: Contribution to journal › Meeting abstract

Original languageEnglish
Pages (from-to)17
Number of pages1
JournalBJU International
Volume116
Issue numberS5
Publication statusPublished - Dec 2015
Externally publishedYes
Event14th International Kidney Cancer Symposium - Miami
Duration: 6 Nov 2015 → 7 Nov 2015

Cite this